Journal of Research in Ayurvedic Sciences

Register      Login

VOLUME 2 , ISSUE 3 ( July-September, 2018 ) > List of Articles

RESEARCH ARTICLE

A Standard Controlled Clinical Study of Varuna Shigru Guggulu and Bala Taila Matra Basti in the Management of Mootraghata (Benign Prostatic Hyperplasia)

Joyal K Patel, Tukaram S Dudhamal

Keywords : Ayurveda,Bala taila,Benign prostatic hyperplasia (BPH),Matra basti,Mootraghata,Varuna shigru guggulu

Citation Information : Patel JK, Dudhamal T S. A Standard Controlled Clinical Study of Varuna Shigru Guggulu and Bala Taila Matra Basti in the Management of Mootraghata (Benign Prostatic Hyperplasia). J Res Ayurvedic Sci 2018; 2 (3):164-171.

DOI: 10.5005/jp-journals-10064-0053

License: CC BY-NC 4.0

Published Online: 00-00-0000

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Mootraghata [benign prostatic hyperplasia (BPH)] is a senile disorder that affects to the people above 40 years of age, having obstructive and irritative symptoms like retention, incomplete voiding, dribbling, hesitancy, incontinence of urine, increased frequency, weak stream, etc. In modern science conservative and surgical both interventions are not free from side effects. So in this age group, there is a need for a safe alternative method of management.

Aim: To evaluate and compare the clinical effect of Varuna shigru guggulu and Matra basti of Bala taila with tamsulosin hydrochloride in the management of Mootraghata w.s.r. to BPH.

Materials and methods: A randomized control clinical trial with two groups was performed. Total 100 patients having signs and symptoms of BPH were selected for the study. In group A Varuna shigru guggulu (500 mg thrice in a day orally) and Bala taila matra basti (60 mL once in a day, through rectal route) and in group B, capsule, tamsulosin hydrochloride, 0.2 mg, twice in a day given orally for 30 days. Both the groups were assessed as per subjective-international prostate symptom score (IPSS), and objective parameters-gradation adopted.

Results: In subjective parameters, group A had shown better result i.e. 75.88 % than the group B (64.22 %). In all objective parameters (Prostate Size, post-void residual urine (PVRU), average urine flow rate (AUFR) group A patients had shown better effect by 14.15 % than group B (10.55%). Hence, group A (trial group) showed better result (65.66%) in overall effect than group B (controlled group i.e. 56.04%)

Conclusion: Finally study Concluded that Varuna shigru guggulu and Bala taila matra basti is safe and effective in the symptomatic management of Mootraghata (BPH) and better option than Tamsulosin Hydrochloride.

Keywords: Ayurveda, Bala taila, Benign prostatic hyperplasia (BPH), Matra basti, Mootraghata, Varuna shigru guggulu

How to cite this article: Patel JK, Dudhamal TS. A Standard Controlled Clinical Study of Varuna Shigru Guggulu and Bala Taila Matra Basti in the Management of Mootraghata (Benign Prostatic Hyperplasia). J Res Ayurvedic Sci. 2018;2(3): 164-171.


PDF Share
PDF Share